CO.DON AG: Negotiations with Xintela on joint venture discontinued
CO.DON AG / Key word(s): Strategic Company Decision
CO.DON AG (ISIN: DE DE000A1K0227)
CO.DON: Negotiations with Xintela on joint venture discontinued
Berlin / Teltow, 17.07.2019 - The negotiations announced on 9 July 2018 with Xintela A.B. regarding the establishment of a joint venture with the aim of developing a stem cell product for the treatment of osteoarthritis are being discontinued.
After careful analysis, the Management Board of CO.DON AG has concluded today that that there is no longer any potential for an agreement to establish a joint venture with Xintela A.B. As a result of the open and constructive discussions, it has now become clear that the assessment of the contribution to be made to the joint venture by the respective parties is too different.
17-Jul-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange|
|EQS News ID:||842463|
|End of Announcement||DGAP News Service|